Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Learoyd

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Medical Case Reports|October 28, 2021
Life-threatening diarrhea in neuroendocrine tumors: two case reportsEmma Gordon, David L Chan, Jennifer Arena, et al.
Annals of Surgical Oncology|September 30, 2010
Medullary thyroid carcinoma: long-term outcomes of surgical treatmentDeepak T Abraham, Tsu-Hui Low, Marinella Messina, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2012
Association of FOXE1 polyalanine repeat region with papillary thyroid cancerMartyn Bullock, Emma L Duncan, Christine O'Neill, et al.
Clinical Endocrinology|December 16, 2015
TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomasMartyn Bullock, Yan Ren, Christine O'Neill, et al.
World Journal of Surgery|October 24, 2013
Patterns of structural recurrence in papillary thyroid cancerSchelto Kruijff, Japke F Petersen, Paul Chen, et al.
Clinical Endocrinology|November 3, 2017
Clinical guidance for radioiodine refractory differentiated thyroid cancerMatti L Gild, Duncan J Topliss, Diana Learoyd, et al.
European Thyroid Journal|September 20, 2021
Change in Practice of Radioactive Iodine Administration in Differentiated Thyroid Cancer: A Single-Centre ExperienceAyanthi Wijewardene, Matti Gild, Carolina Nylén, et al.
Endocrine Oncology (Bristol, England)|July 12, 2023
Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines updateBenjamin J Worrall, Alexander Papachristos, Ahmad Aniss, et al.
Surgery|September 14, 2019
Early postoperative stimulated serum thyroglobulin quantifies risk of recurrence in papillary thyroid cancerJayani Jayasekara, Pascal Jonker, Jia Feng Lin, et al.
The Oncologist|August 26, 2023
Management of Medullary Thyroid Cancer: Patterns of Recurrence and Outcomes of Reoperative SurgeryAlexander J Papachristos, Laura E Nicholls, Robert Mechera, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Medical Case Reports|October 28, 2021
Life-threatening diarrhea in neuroendocrine tumors: two case reportsEmma Gordon, David L Chan, Jennifer Arena, et al.
Annals of Surgical Oncology|September 30, 2010
Medullary thyroid carcinoma: long-term outcomes of surgical treatmentDeepak T Abraham, Tsu-Hui Low, Marinella Messina, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2012
Association of FOXE1 polyalanine repeat region with papillary thyroid cancerMartyn Bullock, Emma L Duncan, Christine O'Neill, et al.
Clinical Endocrinology|December 16, 2015
TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomasMartyn Bullock, Yan Ren, Christine O'Neill, et al.
World Journal of Surgery|October 24, 2013
Patterns of structural recurrence in papillary thyroid cancerSchelto Kruijff, Japke F Petersen, Paul Chen, et al.
Clinical Endocrinology|November 3, 2017
Clinical guidance for radioiodine refractory differentiated thyroid cancerMatti L Gild, Duncan J Topliss, Diana Learoyd, et al.
European Thyroid Journal|September 20, 2021
Change in Practice of Radioactive Iodine Administration in Differentiated Thyroid Cancer: A Single-Centre ExperienceAyanthi Wijewardene, Matti Gild, Carolina Nylén, et al.
Endocrine Oncology (Bristol, England)|July 12, 2023
Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines updateBenjamin J Worrall, Alexander Papachristos, Ahmad Aniss, et al.
Surgery|September 14, 2019
Early postoperative stimulated serum thyroglobulin quantifies risk of recurrence in papillary thyroid cancerJayani Jayasekara, Pascal Jonker, Jia Feng Lin, et al.
The Oncologist|August 26, 2023
Management of Medullary Thyroid Cancer: Patterns of Recurrence and Outcomes of Reoperative SurgeryAlexander J Papachristos, Laura E Nicholls, Robert Mechera, et al.
Pageof 3